8-K: The Joint Corp. to Restate Financials Due to Accounting Error, Improving Reported Net Income

The Joint Corp. announced it will restate its 2024 annual and Q1 2025 financial statements due to a misapplication of accounting guidance for assets held for sale, which is expected to reduce net losses and increase net income.

Summary

• The Joint Corp. will restate its audited financial statements for the year ended December 31, 2024 (Form 10-K) and unaudited interim financial statements for the quarter ended March 31, 2025 (Form 10-Q).
• The restatement is due to a misapplication of accounting guidance related to the valuation methodology for impairment on company-owned or managed clinics classified as held for sale and included in discontinued operations.
• For the year ended December 31, 2024, the correction is expected to reduce the previously reported loss from discontinued operations before income taxes by approximately $2.2 million, resulting in an estimated $2.2 million decrease in net loss and a $2.2 million increase in the carrying value of assets held for sale.
• For the quarter ended March 31, 2025, the correction is expected to increase previously reported income from discontinued operations before income taxes by approximately $0.5 million, resulting in an estimated $0.5 million increase in net income and a cumulative $2.7 million increase in the carrying value of assets held for sale.
• These adjustments are not expected to impact Adjusted EBITDA, cash, cash equivalents, or restricted cash for either period.
• The company expects the evaluation of the errors to result in a material weakness in internal control over financial reporting and a conclusion that disclosure controls and procedures were ineffective.

Sentiment

Score: 6

Explanation: While the restatement itself indicates control weaknesses, the financial impact of the correction is positive (improving reported net income/reducing net loss) and does not affect cash or Adjusted EBITDA. The company is actively addressing the issue.

Positives

• Expected $2.2 million decrease in net loss for the year ended December 31, 2024.
• Expected $0.5 million increase in net income for the quarter ended March 31, 2025.
• No expected impact on Adjusted EBITDA for either period.
• No expected impact on cash, cash equivalents, or restricted cash for either period.
• Increased carrying value of assets held for sale by $2.2 million for 2024 and a cumulative $2.7 million for Q1 2025.

Negatives

• Previously issued financial statements for 2024 and Q1 2025 contained material errors and should no longer be relied upon.
• Expectation of a material weakness in internal control over financial reporting.
• Expectation that disclosure controls and procedures were ineffective during the applicable periods.
• Need to restate and reissue financial statements (Form 10-K/A and 10-Q/A).

Risks

• Inability to identify and recruit enough qualified chiropractors and other personnel to staff clinics, partly due to nationwide labor shortage and increased operating expenses.
• Inflation leading to increased labor costs and interest rates, and changes to import tariffs, potentially reducing discretionary spending and negatively impacting business.
• Failure to profitably operate company-owned or managed clinics.
• Failure to refranchise as planned.
• Short-selling strategies and negative opinions posted on the internet, which could drive down the market price of common stock and result in class action lawsuits.
• Failure to remediate future material weaknesses in internal control over financial reporting, which could negatively impact the ability to accurately report financial results, prevent fraud, or maintain investor confidence.

Future Outlook

The company plans to restate and reissue the affected financial statements (Form 10-K/A and 10-Q/A) as soon as practical. It expects to conclude that there is a material weakness in internal control over financial reporting and that disclosure controls and procedures were ineffective during the relevant periods, and is evaluating and implementing remedial measures.

Management Comments

• Our Chief Financial Officer, after meeting with the members of the Audit Committee of our Board of Directors to discuss the matters disclosed in this Item 4.02 and in consultation with BDO USA, LLP (BDO), our independent registered public accounting firm, concluded that our previously issued audited financial statements as of and for the year ended December 31, 2024 contained in our Annual Report on Form 10-K for the year ended December 31, 2024 and the unaudited interim financial statements contained in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (collectively, the Previously Issued Financial Statements) contained material errors and should be restated, which conclusion was thereafter formally ratified by our Audit Committee and our Board of Directors.
• We are in the process of, but have not yet completed, our determination of the degree to which these errors will have an effect on our Previously Issued Financial Statements.
• We plan to restate and reissue the Previously Issued Financial Statements to reflect the revised method of accounting for non-cash impairment charges related to the assets held for sale.
• We intend to file, as soon as practical, an amended Annual Report on Form 10-K/A and an amended Quarterly Report on Form 10-Q/A, which will contain the restated Previously Issued Financial Statements utilizing the correct methods of accounting.
• We are also evaluating the impact of the identified errors on our internal control over financial reporting and disclosure controls and procedures. Although the evaluation is not yet complete, we expect it will result in a material weakness in our internal control over financial reporting and will conclude that our disclosure controls and procedures were ineffective during the applicable periods related to the Previously Issued Financial Statements.
• We continue to evaluate and implement remedial measures to address such material weaknesses.

Industry Context

The Joint Corp. is the nation's largest franchisor of chiropractic care through The Joint Chiropractic network. This announcement pertains to an accounting misapplication related to the valuation of company-owned or managed clinics classified as held for sale, which is a specific financial reporting issue rather than a broader industry trend or operational challenge affecting the chiropractic sector as a whole. The company's business model focuses on making quality care convenient and affordable, eliminating the need for insurance.

Corporate Governance

Stakeholder Impact

• Shareholders: Previously issued financial statements should no longer be relied upon, potentially causing uncertainty. However, the restatement is expected to improve reported net income/reduce net loss, which is a positive correction. The material weakness in internal controls could impact investor confidence.
• Management: Responsible for addressing and remediating internal control weaknesses.
• Auditors (BDO USA, LLP): Consulted on the matter and involved in the determination of material errors.

Next Steps

• Restate and reissue the Previously Issued Financial Statements.
• File an amended Annual Report on Form 10-K/A.
• File an amended Quarterly Report on Form 10-Q/A.
• Complete evaluation of the impact of identified errors on internal control over financial reporting and disclosure controls and procedures.
• Evaluate and implement remedial measures to address material weaknesses.

Key Dates

Recommendation

While the financial impact of the restatement is positive (improving reported net income and not affecting cash/EBITDA), the underlying issue of a material accounting error and expected material weakness in internal controls introduces uncertainty and governance concerns. Investors should hold to observe the successful completion of the restatement, remediation of control weaknesses, and subsequent financial reporting before making further investment decisions. The positive financial correction is offset by the control deficiencies.

Keywords

The Joint Corp., JYNT, SEC filing, 8-K, financial restatement, accounting error, GAAP, impairment, discontinued operations, internal controls, material weakness, chiropractic care, franchisor, financial reporting